| Name | Remifentanil Mylan |
| Description | Remifentanil is a selective ?-opioid agonist with a rapid onset and very short duration of action. |
| Active Ingredient | Remifentanil |
| Indication | Remifentanil is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia. Remifentanil is indicated for provision of analgesia in mechanically ventilated intensive care patients 18 years of age and over. |
| Strengths | 1mg, 2mg and 5mg |
| Business Partner | Mylan |
| Origin | France |